Company Profile

DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc.
At the end of 2022, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.


Source: Cofisem - Last Update: 2023-10-25

Key Executives
Chief Executive Officer Carlo Rosa
Chief Financial Officer Piergiorgio Pedron
Investor Relations Director Riccardo Fava
Chief Communication Officer Riccardo Fava
Chief Human Resources Officer Stefano Ronchi


Source: Cofisem - Last Update: 2023-07-25

Key Figures
Millenium 2022 2021 2020 2019 2018
Net sales 1,361,138 1,237,654 881,305 706,319 669,200
Income from ordinary activities 1,361,138 1,237,654 881,305 706,319 669,200
Operating income 351,260 419,499 324,226 217,861 204,500
Cost of financial indebtedness net 34,611 22,506 1,375 1,279 0
Equity-accounted companies contribution to income
Net profit from discontinued activities
Net income 240,110 310,732 248,296 175,735 158,100
Net income (Group share) 240,907 310,968 247,871 175,735 158,100
Fiscal year end 12.22 12.21 12.2 12.19 12.18
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards

Source: Cofisem - Last Update: 2023-10-25

Shareholder information
Finde SS 44.98 %
Free float 39.43 %
Carlo Rosa 8.36 %
Chen Menachem Even 4.2 %
T. Rowe Price Associates, Inc. 3.03 %


Source: Cofisem - Last Update: 2023-10-25

Please contact MyQuestion.Italy@euronext.com for Company Profile support.

Quotazioni, Book, Dividendi, Documenti Societari, Corporate Governance, Internal Dealing di Diasorin


The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.


You will be redirected in five seconds.